Published the monthly exercise status of the 25th stock acquisition rights (with exercise price adjustment clause). Number of shares granted in the target month: 66,700 shares; rights actually exercised: 667; exercise ratio against total issued 86,000 rights: 0.77%; unexercised shares at month-end: 37,266 shares. Share transfers on exercise occurred on multiple dates.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"price_fetched_at":"","company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"7776","jir_company_name":"CellSeed Inc.","jir_importance":"\u2605\u2605\u2605\u2606\u2606","jir_publication_date":"2026-10-01","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/10\/7776-20261001-01.pdf","jir_short_summary":"Published the monthly exercise status of the 25th stock acquisition rights (with exercise price adjustment clause). Number of shares granted in the target month: 66,700 shares; rights actually exercised: 667; exercise ratio against total issued 86,000 rights: 0.77%; unexercised shares at month-end: 37,266 shares. Share transfers on exercise occurred on multiple dates.","jir_summary":"### Overview\nCellSeed Inc. has published the monthly exercise status for September 2026 of the 25th stock acquisition rights (with exercise price adjustment clause) issued on December 8, 2025. The number of shares granted in the target month was 66,700 shares, and the number of rights actually exercised was 667, representing an exercise ratio of 0.77% against the total issued 86,000 rights. The number of unexercised shares at month-end decreased from 37,933 shares at the end of the previous month to 37,266 shares. Exercises were distributed across multiple dates from September 3 to September 30, with the largest number of exercises, 23,200 rights, confirmed on September 18.\n\n### Impact on Shareholders and Outlook\nThis report provides quantitative disclosure of exercise status and does not indicate any direct changes to capital policy for shareholders. Continuous monitoring of the remaining unexercised rights is necessary, and depending on future total issued numbers and market exercise trends, dilution effects may occur. For details, refer to past disclosed materials (the third-party allotment related information published in November 2025).","jir_financial_highlights":"Number of shares granted: 66,700 shares (Unknown)\nNumber of stock acquisition rights exercised: 667 rights (Unknown)\nExercise ratio to total issued: 0.77% (Unknown)\nUnexercised stock acquisition rights (at end of previous month): 37,933 rights (Unknown)\nUnexercised stock acquisition rights (at month-end): 37,266 rights (Unknown)","jir_category":"","jir_hashtags":"#CellSeed, #StockAcquisitionRights, #StockOptionExerciseStatus","jir_key_figures":"Number of shares granted: 66,700 shares\nNumber exercised: 667 rights\nTotal issued: 86,000 rights\nUnexercised rights (end of previous month): 37,933 rights\nUnexercised rights (month-end): 37,266 rights","jir_meta_title":"CellSeed Inc. Announces Monthly Exercise Status of Stock Acquisition Rights | September 2026","jir_meta_description":"CellSeed Inc. discloses the monthly exercise status for September 2026 of the 25th stock acquisition rights: 66,700 shares granted, 667 rights exercised, exercise ratio 0.77%, 37,266 unexercised rights at month-end, and other key points.","jir_og_title":"CellSeed Inc. | Monthly Exercise Status of Stock Acquisition Rights Announced","jir_og_description":"CellSeed Inc. published the September exercise status of the 25th stock acquisition rights: 66,700 shares granted, 667 rights exercised, 37,266 unexercised rights at month-end, and detailed breakdowns.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[]","ir_related_company":59075,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"stock_option","footnotes":""},"sector":[],"importance":[],"class_list":["post-126411","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n